Eveready targets mosquito-control sales above Rs 100 crore
Key highlights
- Eveready said mosquito racquets and portable vapourisers could generate more than Rs 100 crore in sales by FY29.
- Eveready management estimated India's liquid-vapouriser market at about Rs 2,800 crore.
- Management said a 3% to 4% liquid-vapouriser market share could become a reality for Eveready.
- Eveready's Q2 FY27 revenue rose 10.7% year on year to Rs 428.2 crore.
powered by IRIS

Eveready Industries India Limited said on November 2, 2026 that sales from mosquito racquets and portable liquid vapourisers could exceed Rs 100 crore by the end of FY29. Management based the ambition on its racquet portfolio, launched within the past three years, and a rechargeable vapouriser now being expanded beyond select markets.
Know Eveready Industries India inside out
Results, valuation, peers and who's buying, in one view.
What is Eveready targeting in mosquito-control sales?
Eveready is targeting more than Rs 100 crore in combined mosquito-control sales by the end of FY29 from racquets and liquid vapourisers. Chief Executive Officer Anirban Banerjee called that outcome realistic during the Q2 and H1 FY27 earnings call, while adding that management could share a more comprehensive future plan sometime in the next quarter.
The goal covers the mosquito portfolio rather than every product introduced in the past 24 months. In H1 FY27, management said half of Eveready's total growth came from core categories and half from newer products in core and new categories, excluding alkaline batteries. Eveready did not disclose current mosquito-product sales, margins, volumes or market share, leaving the FY29 starting base unspecified.
The Rs 100 crore figure is a management ambition and not reported revenue for Q2 FY27 or H1 FY27. The call therefore does not provide an annual growth rate needed for the portfolio to reach the target, nor does it separate the expected contribution of racquets from the newly introduced vapouriser.
Which mosquito products will support Eveready's FY29 goal?
Eveready expects mosquito racquets and portable liquid vapourisers to support the FY29 goal. Management said the racquet portfolio had made Eveready one of the leading participants in the organised segment within less than three years of launch, although it gave no sales value, market-share percentage or definition of the ranking.
The newer product is a rechargeable portable liquid mosquito vapouriser for which Eveready has applied for a patent. Unlike conventional plugged-in vapourisers, the product can be unplugged and used portably. Eveready initially launched it in select markets and said its immediate priorities are wider distribution, consumer awareness and adoption; it did not identify the markets, outlet count or number of stock-keeping units.
The two formats have different roles in the portfolio. Racquets are an established new-category offering, while the vapouriser is the more recent anti-mosquito repellent entry being scaled after a selective rollout. Eveready also launched the SHOR rechargeable flashlight and Xtrabright emergency LED bulb, but neither belongs to the more-than-Rs-100-crore mosquito target.
Those other product launches provide context for the company's broader diversification effort in Q2 FY27. Rechargeable flashlight sales grew 33.2% year on year, while emergency light-emitting diode, or LED, bulb sales grew 26%. Eveready did not provide comparable Q2 growth or sales figures for the racquet and vapouriser businesses.
Got a follow-up? Ask IRIS
How large is the liquid-vapouriser market for Eveready?
Eveready management put India's liquid-vapouriser market at about Rs 2,800 crore and said it has been tightly held by three or four players for almost two decades. The figure followed an analyst's reference to a roughly Rs 3,000 crore market, and management described Rs 2,800 crore as its own approximate estimate during the November 2 call.
Management said a 3% to 4% position could become a reality for Eveready, but it did not attach a date to that expectation. A 3% share of a Rs 2,800 crore market equals Rs 84 crore, while a 4% share equals Rs 112 crore. Those calculations illustrate the comments made on the call and are not management revenue guidance for vapourisers.
The implied Rs 84 crore to Rs 112 crore range should not be equated directly with the combined FY29 portfolio target. The more-than-Rs-100-crore target includes mosquito racquets, whereas the 3% to 4% discussion concerned liquid vapourisers. Management also identified entrenched Indian organisations and multinational companies as existing competitors in this concentrated market.
What will determine Eveready's expansion pace?
Eveready's distribution reach and newer selling channels may support the rollout, but the company has not provided mosquito-specific distribution data. In Q2 FY27, e-commerce and quick-commerce penetration increased more than 50% year on year. Eveready said it is using distribution expansion and consumer awareness-building to develop demand for the portable vapouriser after its select-market launch.
At the company level, Q2 FY27 revenue rose 10.7% year on year to Rs 428.2 crore, marking the eighth consecutive quarter of year-on-year revenue growth. Earnings before interest, tax, depreciation and amortisation, or EBITDA, increased 8.9% to Rs 53.8 crore, and EBITDA margin was 12.6%. These figures cover all businesses and do not measure mosquito-category performance.
Input costs remain relevant to the wider operating backdrop. Average zinc prices were 36% higher year on year in Q2 FY27, and management said material costs, channel mix and product mix caused a 20-basis-point EBITDA-margin contraction. Management expects pricing corrections to recover most of the pressure in Q3, with any remaining recovery expected in Q4.
Eveready's Jammu facility, which started commercial production in May 2026 and billing in September 2026, is intended for alkaline batteries rather than mosquito products. Management said Jammu accounted for not more than 10% of alkaline-battery sales in the September quarter. The facility is relevant to company-wide cost plans but is not a stated production mechanism for racquets or vapourisers.
Conclusion
Eveready has set its first quantified mosquito-control ambition at more than Rs 100 crore by FY29, combining a racquet business established within three years and a portable vapouriser launched in select markets. Management's estimate of a Rs 2,800 crore liquid-vapouriser market and its 3% to 4% share expectation indicate the scale it believes could be available, but current category revenue and profitability remain undisclosed.
The next disclosed milestone is the more comprehensive mosquito-category plan that management said it could share in the next quarter. Readers should also watch whether Eveready specifies the vapouriser rollout, reports category sales, or updates its 3% to 4% share expectation as it expands distribution beyond the initial markets.


